Benzenesulfonamides
Filtered Search Results
FASN-IN-4, MedChemExpress
MedChemExpress FASN-IN-4 is a potent inhibitor of fatty acid synthase (FASN) with an IC50 of 10 nM (WO2012064642A1, compound 29). FASN-IN-4 also inhibits SARS-CoV-2 with an EC50 of 18.6 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
AKR1C3-IN-1, MedChemExpress
MedChemExpress AKR1C3-IN-1 is a potent, highly selective inhibitor of AKR1C3, with an IC50 of 13 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 317.36 |
|---|---|
| Color | Light Yellow |
| Physical Form | Solid |
| Chemical Name or Material | AKR1C3-IN-1 |
| Grade | Research |
| SMILES | O=S(N1CC2=CC=CC=C2CC1)(C3=CC(C(O)=O)=CC=C3)=O |
| Percent Purity | 98.74% |
| CAS | 327092-81-9 |
| Solubility Information | DMSO : ≥ 100 mg/mL (315.10 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C16H15NO4S |
| Formula Weight | 317.36 |
NXT629, MedChemExpress
MedChemExpress NXT629 is a potent, selective, and competitive PPAR-α antagonist, with an IC50 of 77 nM for human PPARα, shows high selectivity over other nuclear hormone receptor, such as PPARδ, PPARγ, ERβ, GR and TRβ, IC50s are 6.0, 15, 15.2, 32.5 and >100 μM, respectively. NXT629 has potent anti-tumor activity and inhibits experimental metastasis of cancer cell in animal models.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 609.78 |
|---|---|
| Color | Light Yellow |
| Physical Form | Solid |
| Chemical Name or Material | NXT629 |
| Grade | Research |
| SMILES | O=S(C1=CC=CC=C1)(NC2=CC=C(C3=CC=C(CCCC(N4CC)=NN(CC5=CC=C(C(C)(C)C)C=C5)C4=O)C=C3)N=C2)=O |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 99.2% |
| CAS | 1454925-59-7 |
| Solubility Information | DMSO : 125 mg/mL (204.99 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C35H39N5O3S |
| Formula Weight | 609.78 |
BMS-303141, MedChemExpress
MedChemExpress BMS-303141 is a potent, cell-permeable ATP-citrate lyase (ACL) inhibitor with an IC50 of 0.13 μM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 424.3 |
|---|---|
| Color | Off-White |
| Physical Form | Powder |
| Chemical Name or Material | BMS-303141 |
| Grade | Research |
| SMILES | O=S(C1=CC(Cl)=CC(Cl)=C1O)(NC2=CC(C3=CC=CC=C3)=CC=C2OC)=O |
| For Use With (Application) | Metabolism-sugar/lipid metabolism |
| Percent Purity | 98.47% |
| CAS | 943962-47-8 |
| Solubility Information | DMSO : 25 mg/mL (58.92 mM; Need ultrasonic) |
| Health Hazard 1 | H302∣H315∣H319∣H335 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C19H15Cl2NO4S |
| Formula Weight | 424.3 |
Acetohexamide, MedChemExpress
MedChemExpress Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2; stimulate the pancreas to secrete insulin.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 324.4 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Acetohexamide |
| Grade | Research |
| SMILES | O=S(C1=CC=C(C(C)=O)C=C1)(NC(NC2CCCCC2)=O)=O |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 99.39% |
| CAS | 968-81-0 |
| Solubility Information | DMSO : 25 mg/mL (77.07 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C15H20N2O4S |
| Formula Weight | 324.4 |
Etebenecid, MedChemExpress
MedChemExpress Etebenecid is a uricosuric agents, lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys, also inhibits penicillin tubular secretion.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
PKR-IN-2, MedChemExpress
MedChemExpress PKR-IN-2 is a pyruvate kinase isoform PKR activator extracted from patent WO2014139144A1, compound 160. PKR-IN-2 can be used for the research of PKR function related diseases, including cancer, diabetes, obesity, autoimmune disorders, and benign prostatic hyperplasia.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 468.57 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | PKR-IN-2 |
| Grade | Research |
| SMILES | N1C2C(=C(S(NC3=CC=C(C(N4CCC(O)(CC(C)C)CC4)=O)C=C3)(=O)=O)C=CC=2)N=CC=1 |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 95.14% |
| CAS | 1628428-01-2 |
| Solubility Information | DMSO : 50 mg/mL (106.71 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C24H28N4O4S |
| Formula Weight | 468.57 |
Orexin 2 Receptor Agonist, MedChemExpress
MedChemExpress Orexin 2 Receptor Agonist is a potent (EC50 on OX2R is 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio is 70) agonist.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 586.7 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Orexin 2 Receptor Agonist |
| Grade | Research |
| SMILES | O=C(C1=CC=CC(C)=C1)NCCNC2=CC(NS(C3=C(OC)C=CC(C4=CC(C(N(C)C)=O)=CC=C4)=C3)(=O)=O)=CC=C2 |
| For Use With (Application) | Neuroscience-Neuromodulation |
| Percent Purity | 99.75% |
| CAS | 1796565-52-0 |
| Solubility Information | DMSO : ≥ 32 mg/mL (54.54 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C32H34N4O5S |
| Formula Weight | 586.7 |
SU11274, MedChemExpress
MedChemExpress SU11274 is a selective Met inhibitor with IC50 of 10 nM, but has no effects on PGDFRβ, EGFR or Tie2.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 568.09 |
|---|---|
| Color | Orange |
| Physical Form | Solid |
| Chemical Name or Material | SU11274 |
| Grade | Research |
| SMILES | O=S(C1=CC2=C(C=C1)NC(/C2=C/C3=C(C(C(N4CCN(CC4)C)=O)=C(N3)C)C)=O)(N(C)C5=CC=CC(Cl)=C5)=O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 98.19% |
| CAS | 658084-23-2 |
| Solubility Information | DMSO : ≥ 100 mg/mL (176.03 mM) |
| Synonym | PKI-SU11274 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C28H30ClN5O4S |
| Formula Weight | 568.09 |
LX2343, MedChemExpress
MedChemExpress LX2343 is a BACE1 enzyme inhibitor with an IC50 value of 11.43±0.36 μM. LX2343 acts as a non-ATP competitive PI3K inhibitor with an IC50 of 15.99±3.23 μM. LX2343 stimulates autophagy in its promotion of Aβ clearance.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 474.91 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | LX2343 |
| Grade | Research |
| SMILES | O=C(NC1=CC=C(OCO2)C2=C1)CN(C3=CC(Cl)=CC=C3OC)S(=O)(C4=CC=CC=C4)=O |
| For Use With (Application) | Neuroscience-Neurodegeneration |
| Percent Purity | 99.74% |
| CAS | 333745-53-2 |
| Solubility Information | DMSO : ≥ 100 mg/mL (210.57 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C22H19ClN2O6S |
| Formula Weight | 474.91 |
Veralipride, MedChemExpress
MedChemExpress Veralipride is a D2 receptor antagonist. It is an alternative antidopaminergic treatment for menopausal symptoms.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 383.46 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Veralipride |
| Grade | Research |
| SMILES | O=C(NCC1N(CC=C)CCC1)C2=CC(S(=O)(N)=O)=CC(OC)=C2OC |
| For Use With (Application) | Neuroscience-Neurodegeneration |
| Percent Purity | 99.57% |
| CAS | 66644-81-3 |
| Solubility Information | DMSO : ≥ 100 mg/mL (260.78 mM) |
| Synonym | (±)-Veralipride LIR166 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C17H25N3O5S |
| Formula Weight | 383.46 |
Hydroxyhexamide, MedChemExpress
MedChemExpress Hydroxyhexamide is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agents.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 326.41 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Hydroxyhexamide |
| Grade | Research |
| SMILES | O=S(C1=CC=C(C(O)C)C=C1)(NC(NC2CCCCC2)=O)=O |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 99.68% |
| CAS | 3168-01-2 |
| Solubility Information | DMSO : ≥ 300 mg/mL (919.09 mM) |
| Synonym | (±)-Hydroxyhexamid |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C15H22N2O4S |
| Formula Weight | 326.41 |
Alofanib, MedChemExpress
MedChemExpress Alofanib (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2). Anticancer and antiangiogenic activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 413.4 |
|---|---|
| Color | Yellow |
| Physical Form | Solid |
| Chemical Name or Material | Alofanib |
| Grade | Research |
| SMILES | O=C(O)C1=CC=CC(S(=O)(NC2=CC(C3=CC=CN=C3)=C(C)C=C2[N+]([O-])=O)=O)=C1 |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 98.81% |
| CAS | 1612888-66-0 |
| Solubility Information | DMSO : ≥ 30.1 mg/mL (72.81 mM) |
| Synonym | RPT835 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C19H15N3O6S |
| Formula Weight | 413.4 |
HMN-176, MedChemExpress
MedChemExpress HMN-176 is a stilbene derivative which inhibits mitosis, interfering with polo-like kinase-1 (plk1), without significant effect on tubulin polymerization.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 382.43 |
|---|---|
| Color | Light Yellow |
| Physical Form | Solid |
| Chemical Name or Material | HMN-176 |
| Grade | Research |
| SMILES | O=S(C1=CC=C(OC)C=C1)(NC2=CC=CC=C2/C=C/C3=CC=N(C=C3)=O)=O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 98.54% |
| CAS | 173529-10-7 |
| Solubility Information | DMSO : ≥ 30 mg/mL (78.45 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C20H18N2O4S |
| Formula Weight | 382.43 |
TG101209, MedChemExpress
MedChemExpress TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, appr 30-fold selective for JAK2 than JAK3, and sensitive to JAK2V617F and MPLW515L/K mutations.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 509.67 |
|---|---|
| Color | Gray |
| Physical Form | Solid |
| Chemical Name or Material | TG101209 |
| Grade | Research |
| SMILES | O=S(C1=CC=CC(NC2=NC(NC3=CC=C(C=C3)N4CCN(CC4)C)=NC=C2C)=C1)(NC(C)(C)C)=O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 98.81% |
| CAS | 936091-14-4 |
| Solubility Information | DMSO : ≥ 50 mg/mL (98.10 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C26H35N7O2S |
| Formula Weight | 509.67 |